Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
CASI | CASI Pharmaceuticals, Inc (DE) | Chairman and CEO, Director, 10%+ Owner | Jun 13, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|